Therapeutic: vamorolone for Duchenne muscular dystrophy
Vamorolone|Cas# 13209-41-1
Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD - Quest | Muscular Dystrophy Association
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function | Neurology
Vamorolone Post-Trial Access
Vamorolone - Wikipedia
VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect
Pharma News | Actinium, Santhera, Gilead, Seres, BMS, Boehringer
Vamorolone treatment following disease induction reduces the severity... | Download Scientific Diagram
1st Patient Dosed in Pilot Trial of Vamorolone for Becker MD | Medication May Work With Fewer Side Effects Than Corticosteroids | Muscular Dystrophy News Today
Vamorolone inhibits inflammatory signaling in macrophage and heart... | Download Scientific Diagram
Participants Sought for Clinical Trial to Test Vamorolone in DMD - Muscular Dystrophy Association
Phase 2a preliminary study results
Investigational steroid mirrors prednisone's benefits while taming its side effects | Children's National
Frontiers | Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Vamorolone | C22H28O4 | CID 3035000 - PubChem
Mechanism of Action - ReveraGen BioPharma
Santhera Shares Community Update on Phase 2b Trial for Vamorolone - Parent Project Muscular Dystrophy
VISION-DMD End Event: Vamorolone Clinical Trial Results • World Duchenne
Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy - Jett Foundation
Vamorolone demonstrates efficacy, safety for boys with Duchenne muscular dystrophy
VISION-DMD newsletter launched at Phase 2 of clinical trial of Vamorolone - Action Duchenne
Development of Vamorolone
In DMD Trial, Vamorolone Shows Efficacy and Safety Over 48 Weeks
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study - Jett Foundation
